The Patent Finder

Ambit Biosciences Corporation

Also on record
Records under this name other than the patents Ambit Biosciences Corporation holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 4 patents it holds.

Back to Ambit Biosciences Corporation

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,129,374Method of Using Imidazolothiazole Compounds for the Treatment of Disease
In force
 · High confidence
In forceHigh confidence
US 8,557,810Imidazolothiazole Compounds for the Treatment of Disease
In force
 · Medium confidence
In forceMedium confidence
US 9,585,892SOLID FORMS COMPRISING N-(5-TERT-BUTYL-ISOXAZOL-3-YL)-N'-{4-[7-(2-Morpholin-4-YL-ETHOXY)IMIDAZO[2,1-b][1,3]BENZOTHIAZOL-2-YL]PHENYL}UREA, COMPOSITIONS THEREOF, AND USES THEREWITH
In force
 · Medium confidence
In forceMedium confidence
US 7,820,657Imidazolothiazole Compounds for the Treatment of Disease
In force
 · High confidence
In forceHigh confidence
US 7,968,543Methods of Administering N-(5-tert-butyl-isoxazol-3-yl)-n'-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea to Treat Proliferative Disease
In force
 · High confidence
In forceHigh confidence
US 8,836,218Methods of Treatment Using Combination Therapy
In force
 · Medium confidence
In forceMedium confidence
US 8,865,710Methods of Treating Proliferative Diseases
In force
 · Medium confidence
In forceMedium confidence
US 9,555,040Methods of Treating Proliferative Diseases
In force
 · High confidence
In forceHigh confidence
US 9,110,054Detectable nucleic acid tag
In force
 · High confidence
In forceHigh confidence
US 8,357,690Methods of Treatment Using Combination Therapy
In force
 · High confidence
In forceHigh confidence
10 of 70 records shown.
Pro members see all 70.
Pro members: see all 70 records
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited